Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Investment
Celanese delays acetic acid and methanol investments
by Craig Bettenhausen
May 2, 2020
| A version of this story appeared in
Volume 98, Issue 17
Citing weakened demand and a need to free up cash in the face of COVID-19 disruptions, Celanese CEO Lori Ryerkerk has told investors that it will delay by 18 months its acetic acid and methanol expansion projects in Texas. Celanese will reduce overall capital expenditures in 2020 to less than $350 million from the planned $500 million. Ryerkerk said the firm expects earnings from its acetyl products and engineered materials businesses to be down 40% this year.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2025 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X